Ignite Creation Date:
2025-12-25 @ 4:18 AM
Ignite Modification Date:
2026-02-23 @ 10:25 PM
Study NCT ID:
NCT03127020
Status:
COMPLETED
Last Update Posted:
2019-06-28
First Post:
2016-04-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 2 Study With PQR309 in Relapsed or Refractory Lymphoma Patients
Sponsor:
PIQUR Therapeutics AG
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-06
Start Date Type:
ACTUAL
Primary Completion Date:
2019-03-21
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2016-04-14
First Submit QC Date:
None
Study First Post Date:
2017-04-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-06-27
Last Update Post Date:
2019-06-28
Last Update Post Date Type:
ACTUAL